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Supplementary Figure 1. Epigenetic regulation of RASSF1A and GATA factor binding 
upon ESC differentiation (a) Histone modifications on RASSF1A, SOX2, GATA4 and 
GAPDH promoter CpG islands in H1 embryonic stem cells versus lymphoblastoid line 
GM12878 representing the mesodermal cell lineage. Transcription-activating 
epigenetic marks (H3K4me1;H3K4me2;H3K4me3;H3K9ac;H3K27ac) are found 
together with repressive marks (H3K9me3;H3K27me3) on the RASSF1A promoter in 
H1 cells, indicating its function as a bivalent promoter during pluripotency, switching 
to its fully active state upon differentiation. The SOX2 promoter is only active during 
pluripotency, whereas the GATA4 promoter remains silent and the GAPDH promoter 
is constitutively active. The analysis was performed using data from the ENCODE 
Project database (b) Experimental controls in ESC demonstrating pluripotency marker 
expression in the presence and absence of LIF (c) GATA binding sites located 
upstream of the mouse Rassf1A promoter (d) Western blot demonstrating that 
GATA1 overexpression induces Rassf1A endogenous levels in the presence of LIF, 
whereas Gata1 KD reverses the phenotype even in the absence of LIF (e) Histone 
marks in siNT versus Gata1-depleted ES cells. *P<0.05 of Student’s t-test. Error bars 
indicate s.e.m. Data shown are representative of at least 3 independent experiments.  
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Supplementary Figure 2. RASSF1A regulates the ESC core pluripotency network (a) 
Representative fluorescent images of Nanog and zsRASSF1A (zsR1A)-expressing ESC. 
(b) Representative images and total cell numbers per condition 24 h post-transfection 
with the indicated constructs. Control: zsCtrl, zsR1A: zsRASSF1A (c) Quantification of 
Nanog-positive cells in the indicated conditions (d) RASSF1A reduces core stem cell 
markers at the mRNA and (e) protein level (f) Representative images and total cell 
numbers per condition 24 h post-transfection with control or RASSF1A-targeting 
siRNAs. qPCR demonstrating RASSF1A KD (g) Upregulation of Nanog using an 
alternative siRNA to Rassf1A minimises the possibility of off-target effects. Scale: 10-
50 μm, *P<0.05 , **P<0.01 and ***P<0.001, respectively, of Student’s t-test. Error 
bars indicate s.e.m. Data shown are representative of at least 3 independent 
experiments. 
Papaspyropoulos et al 
a 
e 
Supplementary Figure 3 
f 
                        siNT siR1Α#2 
   IP: 
 YAP 
Input 
   shGFP          -        -       +       -        -       + 
   shRassf1Α   +        +       -       +       +       - 
   siYap            -        +       -       -        +       -   
 
IP: TEAD2 
YAP 
GAPDH 
Input 
β-cat 
TEAD2 
b 
c 
g 
Flag-YAP IP 
Yap1 
Tcf7L1 Tead 
Log10 pValue 
Log
2  Fold 
ChIPseq Inputs 
ESC              ESC +zsRASSF1A 
Birc5 
100 
 
 
0 
100 
 
 
0 
  100 
 
 
0 
  100 
 
 
0 
100 
 
 
0 
100 
 
 
0 
Jub 
Bcl2l1 
Yap/β-catenin 
0
1
2
*** 
  
m
R
N
A 
[F
ol
d]
 
     siNT 
     siR1Α #2 
TEAD2 
β-cat 
YAP 
TEAD2 
β-cat 
YAP 
GAPDH 
Oct4 
Oct4 
abs 
29 6.5 
elution volume 
MW KDa 
ESC +LIF 
ESC –LIF d4  
Fraction 1-14 
d 
443 669 2,500 150 66 
                           shGFP              +        -        +        - 
                           shRassf1Α        -         +       -         + 
   
IP:YAP 
Input 
TEAD2 
β-cat 
YAP 
GAPDH 
0
2
4
6
8
10
12
** 
YAP/β-catenin 
* 
R
el
at
iv
e 
ra
tio
 
YAP/TEAD2 
55 KDa 
100 KDa 
70 KDa 
55 KDa 
100 KDa 
70 KDa 
35 KDa 
40 KDa 
40 KDa 
55 KDa 
100 KDa 
70 KDa 
35 KDa 
100 KDa 
55 KDa 
70 KDa 
35 KDa 
Supplementary Figure 3. RASSF1A-driven YAP complexes are transcriptional 
regulators (a) Average profile of ChIP enrichment signal in genes differentially 
expressed upon RASSF1A knockdown. Relative enrichment of YAP binding sites in 
proximal and distal regions of the differentially expressed genes over the background 
(whole genome). TSS:Transcription Start Site, TTS:Transcription Termination Site (b) 
Technical controls for YAP ChIP-seq. Total sheared chromatin inputs from the 
indicated conditions depicting equal occupancy of classical YAP-β-catenin target 
genes (c) Volcano plot of the Flag-YAP interactome in ESC in response to RASSF1A 
loss. All mass-spec intensities were normalized to YAP intensities for each sample to 
ensure equal loading. See also Supplementary Data 3. In the absence of RASSF1A, 
YAP-TEAD and YAP-TCF3 complexes are stabilised (d) elution volumes and absorbance 
traces from gel filration column of ESC lysates. Fractions selected for main figure size 
exclusion figures indicated with red bar and elution fraction of molecular weight 
markers (top) (e) Western blotting of YAP immunoprecipitates using an additional 
siRNA to RASSF1A, identifying a different region of the target sequence (siRassf1A 
#2). qPCR showing the efficiency of siRassf1A #2 (f) Western blotting of Yap 
immunoprecipitates in shGFP and shRassf1A-expressing ESC lines, validating 
increased association of YAP with both TEAD2 and β-catenin upon RASSF1A loss. Bar 
graphs represent quantification of the TEAD2 and β-catenin relative ratio to YAP (g) 
Western blotting of TEAD2 immunoprecipitates and totals from ESC with the 
indicated antibodies. YAP is required for TEAD2-β-catenin complex formation. 
*P<0.05  and **P<0.01, respectively, of Student’s t-test. Error bars indicate s.e.m. 
Data shown are representative of at least 3 independent experiments.  
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Supplementary Figure 4. RASSF1A loss-mediated effects require intact YAP, TEAD2 
and β-catenin (a) Control for the generation of stable shRASSF1A-expressing ESC 
lines (b) Western blotting demonstrating efficient siRNA-mediated silencing of β-
catenin, TCF7L1(TCF3) and TCF7L2 (TCF4) in ESC, corresponding to Fig. 3g and 
Supplementary Fig. 5a and b (c) Control for the generation of stable shTEAD2-
expressing ESC cell lines (d) Impact of RASSF1A/YAP, RASSF1A/β-catenin and 
RASSF1A/TEAD1 depletion on core stem cell marker expression in ESC. Tead1 
depletion is used as a control. Its depletion leads to increased stem cell marker 
expression, verifying its function as a differentiation marker (e) Impact of 
RASSF1A/TEAD2 depletion on stem cell marker expression in ESC and (f) iPSC. 
***P<0.001, of Student’s t-test. Error bars indicate s.e.m. Data shown are 
representative of at least 3 independent experiments. 
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Supplementary Figure 5. RASSF1A regulates the pluripotency network via the 
MST/LATS pathway (a) TEAD2 and (b) β-catenin ChIP on Tead2 and β-catenin binding 
sites (BS) on the ESC Pou5f1/Oct4 promoter in response to the indicated conditions. 
Intact YAP-TEAD2-β-catenin transcriptional complexes are recruited on the Pou5f1 
distal enhancer upon RASSF1A loss  (c) YAP ChIP on TEAD2 and TCF binding sites (BS) 
on the ESC Pou5f1/Oct4 promoter in response to indicated conditions (d) Impact of 
RASSF1A/MST2 and RASSF1A/LATS1 depletion on core stem cell markers in ESC. The 
MST/LATS kinase cascade is required for stem cell marker upregulation in response to 
RASSF1A loss ***P<0.001, of Student’s t-test. Error bars indicate s.e.m. Data shown 
are representative of at least 3 independent experiments. 
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Supplementary Figure 6. LATS-dependent YAP phosphorylation in response to 
RASSF1A (a) Western blots for S127-YAP and Y357-YAP phosphorylation levels. Y357-
Yap phosphorylation was used as a control; although present, it does not change in 
response to RASSF1A. S127-YAP phosphorylation follows RASSF1A levels (b) Negative 
control for PLA experiment in Fig. 4f and FLAG expression in FLAG-YAP transfected 
ESC (c) YAP ChIP on Tead1 gene promoter (d) Western blot controls for Fig 4g (e) 
Western blot controls for Fig 4h (f) YAP ChIP on differentiation-related gene 
promoters in response to indicated conditions in the absence of LIF and (g) RNAseq 
data displaying  mRNA expression levels of the respective genes.   
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Supplementary Figure 7 
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Supplementary Figure 7. RASSF1A regulates the core pluripotency network in the 
pre-implantation embryo (a) Oct4 inactivation and knockdown in mESC increases 
RASSF1 and differentiation-promoting, RASSF1-dependent transcripts (GEO datasets 
GDS3599:GSE17439 and GDS1824:GSE4189 respectively). Those phenotypes are 
recapitulated upon differentiation of hESC lines H1 and H9 (GEO dataset 
GDS5408:GSE54186). Similarly, loss of the RASSF1A suppressor Brg1 in the 2-cell pre-
implantation embryo leads to increase of Rassf1A and Rassf1-regulated transcripts. 
Data deriving from GEO dataset GDS2156:GSE5371 (b) Top: Experimental process for 
in vivo experiments. Zygotes (E0.5) were microinjected with various fate 
determinants and controls and allowed to develop until blastocysts were formed 
(app. E4.0). Bottom: Experimental control for siRNA-mediated Rassf1a KD in the 
mouse embryo (c) Top: Representative images of embryos microinjected with either 
non-targeting siRNA (siNT) or siRNAs targeting RASSF5, demonstrating increased core 
stem cell marker expression upon RASSF5 loss. Bottom: qPCR for Oct4 and Nanog 
expression from the transfected embryos (d) Percentage of blastocyst forming 
embryos upon microinjection of the indicated concentration of Rassf1A mRNA versus 
Control (e) Control embryos microinjected with empty vector and non-targeting 
siRNA (siNT) or sip73 develop normally to the blastocyst stage, n=5. BF: Brightfield 
channel. Scale: 50 μm, *P<0.05 and***P<0.001, respectively, of Student’s t-test. 
Error bars indicate s.e.m. Data shown are representative of at least 3 independent 
experiments.  
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Supplementary Figure 8. Characterization of iPS cells (a) Experimental procedure of iPSC and 
embryoid bodies generation (b) Top: Western blot showing induction of HA-RASSF1A in 
Rassf1A-/- MEFs. Bottom: qPCR showing equal expression levels of the SKOM construct in 
iPSC. Untransfected MEFs were used as negative control (c) Representative images of 
indicated staining in iPSC. Rassf1A-/- iPSC express higher levels of core pluripotency markers 
NANOG and SOX2 than Rassf1A+/+ counterparts (d) Western blotting of YAP 
immunoprecipitates in Rassf1A+/+,-/- and -/-+HA-RASSF1A iPSC with the indicated antibodies (e) 
Proteomics analysis for differences in pS127-YAP in RASSF1A-expressing versus non-
expressing iPSC. All cells are transfected with a FLAG-YAP1 (human) construct. All mass-spec 
intensities were normalized to YAP intensities for each sample. See also Supplementary Table 
4 (f) qPCR for differentiation markers Nestin (ectoderm) and Vimentin (mesoderm-
endoderm) from indicated conditions, following LIF withdrawal for 96 h (g) qPCR for the 
differentiation marker Nestin in the indicated conditions, following LIF withdrawal for 96h (h) 
Quantification of round colonies 4 days after LIF withdrawal (i) Embryoid bodies (EB) forced 
to differentiate towards the dendritic cell (DC) lineage upon GM-CSF and rIL-3 treatment. 
From left to right: Rassf1A-/- EBs maintain round iPSC shape; Dendritic cell (DC)-specific cd54 
marker expression upon induction of differentiation, assessed via FACS. The bar graphs 
illustrate cd54-expressing cells in the absence of LPS; LPS used as positive control to activate 
DCs. The bar graphs illustrate cd11c expressing cells in the presence of LPS (j) Example 
images of iPSC staining with the proliferation marker Ki67 to assess cell cycle exit (k) Rassf1A-
/- MEFs are insensitive to TGFβ-mediated disruption of reprogramming, in contrast to 
Rassf1A+/+ MEFs, indicating that Rassf1A-mediated regulation of pluripotency may be 
dominant over induction of mesenchymal-to-epithelial transition (MET). Scale bars: 25-50 
μm. *P<0.05, **P<0.01 and ***P<0.001, respectively, of Student’s t-test. Error bars indicate 
s.e.m. Data shown are representative of at least 3 independent experiments. 
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Supplementary Figure  9. Uncropped scans of blots from indicated figures 
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Supplementary Figure  11. Uncropped scans of blots from indicated figures 
